[vc_row][vc_column][vc_column_text]CRISM developed the first national injectable opioid agonist treatment (iOAT) guideline in the world. This guideline includes two companion documents: a clinical guideline and an operational guidance document.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_single_image image=”10380″ img_size=”medium” style=”vc_box_border”][vc_btn title=”CLINICAL GUIDELINE (En)” color=”peacoc” align=”left” link=”url:https%3A%2F%2Fcrism.ca%2Fwp-content%2Fuploads%2F2019%2F09%2FCRISM_National_IOAT_Clinical_Guideline-10Sep2019-English-FINAL.pdf||”][mk_padding_divider size=”33″][mk_padding_divider size=”33″][/vc_column][vc_column width=”1/2″][vc_single_image image=”10379″ img_size=”medium” style=”vc_box_border”][vc_btn title=”CLINICAL GUIDELINE (Fr)” color=”peacoc” align=”left” link=”url:https%3A%2F%2Fcrism.ca%2Fwp-content%2Fuploads%2F2019%2F09%2FCRISM_National_IOAT_Clinical_Guideline-French-FINAL.pdf||target:%20_blank”][mk_padding_divider size=”33″][mk_padding_divider size=”33″][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_single_image image=”10386″ img_size=”medium” style=”vc_box_border”][vc_btn title=”OPERATIONAL GUIDANCE (En)” color=”peacoc” align=”left” link=”url:https%3A%2F%2Fcrism.ca%2Fwp-content%2Fuploads%2F2019%2F09%2FCRISM_National_IOAT_Operational_Guideline-17Sept2019-English-FINAL.pdf||”][/vc_column][vc_column width=”1/2″][vc_single_image image=”10385″ img_size=”medium” style=”vc_box_border”][vc_btn title=”OPERATIONAL GUIDANCE (Fr)” color=”peacoc” align=”left” link=”url:https%3A%2F%2Fcrism.ca%2Fwp-content%2Fuploads%2F2019%2F09%2FCRISM_National_IOAT_Operational_Guideline-French-FINAL.pdf||target:%20_blank”][/vc_column][/vc_row][vc_row][vc_column][mk_padding_divider size=”33″][vc_column_text]A synopsis of the Guideline was published in the Canadian Medical Association Journal
A podcast was also produced by CMAJ, which can be found at the link above.
You can also access the Guideline Development Methodology (as supplied by the authors) here[/vc_column_text][mk_padding_divider size=”33″][mk_custom_list title=”Supplemental Materials”]
- Supervised Consumption Sites vs iOAT | English | French
- Sample Program Expectations | English | French
- Sample Patient Bill of Rights | English | French
- Sample Client Safety Care Plan | English | French
- Sample Treatment Plan | English | French
- Sample Floor Plan | English | French
- Lessons Learned | English | French
- FAQ for Patients and Families | English | French
- Case Studies | English | French
- Sample Diacetylmorphine Titration Pre-Printed Order | English | French
- Sample Hydromorphone Titration Pre-Printed Order | English | French
- Sample Hydromorphone Titration Hospital Pre-Printed Order Package | English | French
- Sample Hydromorphone Maintenance Pre-Printed Order | English | French
- Journal Article: Perspectives of people with opioid use disorder on improving addiction treatments and services (Lachapelle, et al, 2020) | English
[/mk_custom_list][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
